医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
21期
141-142
,共2页
舒芬太尼%丙泊酚%腹腔镜子宫切除术%全凭静脉麻醉
舒芬太尼%丙泊酚%腹腔鏡子宮切除術%全憑靜脈痳醉
서분태니%병박분%복강경자궁절제술%전빙정맥마취
Sufentanil%Propofol%Laparoscopic hysterectomy%Total intravenous anaesthesia
目的:探讨不同剂量舒芬太尼联合丙泊酚麻醉对腹腔镜下子宫切除术的效果。方法拟行腹腔镜下子宫切除术120例随机分为三组(S1、S2、S3)。术中采用持续输注舒芬太尼和丙泊酚5~10mg.kg-1.h-1维持麻醉,S1组输注舒芬太尼0.2μg.kg-1.h-1、S2组输注舒芬太尼0.4μg.kg-1.h-1、S3组输注舒芬太尼0.6μg.kg-1.h-1。记录舒芬太尼和丙泊酚使用情况;MAP、HR、自主呼吸恢复时间、清醒时间、出现疼痛时间;术中知晓,苏醒时躁动、呕心/呕吐、疼痛发生情况。结果①S3组舒芬太尼量高于S2组与S1组,丙泊酚量低于S2和S1组(P<0.05); S3组术中推注10μg舒芬太尼例数和次数低于S2组和S1组,S2组低于S1组(<0.05)。②各组同时点MAP和HR无统计学意义(>0.05);组内比较,各组T1时点MAP和HR均低于T0及其它时点(<0.05);③S3组自主呼吸恢复时间、苏醒时间及出现疼痛时间长于S1组与S2组(<0.05);④S3组苏醒时疼痛发生率低于S1组和S2组(<0.05)。结论术中持续输注舒芬太尼联合丙泊酚全凭静脉麻醉可为腹腔镜下子宫切除提供满意的麻醉效果,增加舒芬太尼输注剂量,可提供更加稳定的血流动力学和良好的术后镇痛。
目的:探討不同劑量舒芬太尼聯閤丙泊酚痳醉對腹腔鏡下子宮切除術的效果。方法擬行腹腔鏡下子宮切除術120例隨機分為三組(S1、S2、S3)。術中採用持續輸註舒芬太尼和丙泊酚5~10mg.kg-1.h-1維持痳醉,S1組輸註舒芬太尼0.2μg.kg-1.h-1、S2組輸註舒芬太尼0.4μg.kg-1.h-1、S3組輸註舒芬太尼0.6μg.kg-1.h-1。記錄舒芬太尼和丙泊酚使用情況;MAP、HR、自主呼吸恢複時間、清醒時間、齣現疼痛時間;術中知曉,囌醒時躁動、嘔心/嘔吐、疼痛髮生情況。結果①S3組舒芬太尼量高于S2組與S1組,丙泊酚量低于S2和S1組(P<0.05); S3組術中推註10μg舒芬太尼例數和次數低于S2組和S1組,S2組低于S1組(<0.05)。②各組同時點MAP和HR無統計學意義(>0.05);組內比較,各組T1時點MAP和HR均低于T0及其它時點(<0.05);③S3組自主呼吸恢複時間、囌醒時間及齣現疼痛時間長于S1組與S2組(<0.05);④S3組囌醒時疼痛髮生率低于S1組和S2組(<0.05)。結論術中持續輸註舒芬太尼聯閤丙泊酚全憑靜脈痳醉可為腹腔鏡下子宮切除提供滿意的痳醉效果,增加舒芬太尼輸註劑量,可提供更加穩定的血流動力學和良好的術後鎮痛。
목적:탐토불동제량서분태니연합병박분마취대복강경하자궁절제술적효과。방법의행복강경하자궁절제술120례수궤분위삼조(S1、S2、S3)。술중채용지속수주서분태니화병박분5~10mg.kg-1.h-1유지마취,S1조수주서분태니0.2μg.kg-1.h-1、S2조수주서분태니0.4μg.kg-1.h-1、S3조수주서분태니0.6μg.kg-1.h-1。기록서분태니화병박분사용정황;MAP、HR、자주호흡회복시간、청성시간、출현동통시간;술중지효,소성시조동、구심/구토、동통발생정황。결과①S3조서분태니량고우S2조여S1조,병박분량저우S2화S1조(P<0.05); S3조술중추주10μg서분태니례수화차수저우S2조화S1조,S2조저우S1조(<0.05)。②각조동시점MAP화HR무통계학의의(>0.05);조내비교,각조T1시점MAP화HR균저우T0급기타시점(<0.05);③S3조자주호흡회복시간、소성시간급출현동통시간장우S1조여S2조(<0.05);④S3조소성시동통발생솔저우S1조화S2조(<0.05)。결론술중지속수주서분태니연합병박분전빙정맥마취가위복강경하자궁절제제공만의적마취효과,증가서분태니수주제량,가제공경가은정적혈류동역학화량호적술후진통。
Objective To evaluate the efficacy of dif erent doses of sufentanil combined with propofol continuous infusion for total intravenous anesthesia in laparoscopic hysterectomy. Methods The 120 patients undergoing laparoscopic hysterectomy were randomly divided into 3 groups (n=40): S1 group, S2 group and S3 group. Anesthesia was maintained with sufentanil and propofol 5~10mg.kg-1.h-1 continuous infusion; S1 group, S2 group, and S3 group received respectively sufentanil 0.2μg.kg-1. h-1, 0.4μg.kg-1.h-1 and 0.6μg.kg-1.h-1. The consumption of sufentanil and propofol were recorded; MAP and HR were recorded; Times to spontaneous ventilation, recovery and pain were record; the incidences of awareness in the intraoperative period, dysphoria, nausea and vomiting, pain in recovery period were record. Results (1) Total sufentanil consumption in S3 group was more than in S1 and S2 group, Total propofol consumption and The bolus of 10?g sufentanil requirement in S3 group was less than in S1 and S2 group ( <0.05). (2) There were no statistical y dif erence in MAP and HR at the same time in three groups ( >0.05); MAP and HR at T1 time in three group was less than at other dif erent time ( <0.05). (3) The time of spontaneous ventilation, recovery and pain in S3 group were longer than in S1 and S2 group ( <0.05). (4) The incidence of pain in S3 group is lower than in S1 and S2 groups after recovery. Conclusion Sufentanil combined with propofol continuous infusion was suitable for maintaining adequate anesthesia in laparoscopic hysterectomy. With increasing dose of sufentanil, it can provide more stable haemodynamics and excellent post-operative analgesia.